The future of the 317 immunization program

By Maria Relaki / 28 December 2011 / 0 comments

Kristin Pope has served as Associate Director for Policy with the National Center for Immunization and Respiratory Diseases (NCIRD) at the Centers for Disease Control and Prevention (CDC) since 2008. Kristin provides leadership in public health policy, partnerships, strategic planning, and performance in meeting the Center’s mission.

At the 12th annual World Vaccine Congress in April 2012 Kristin will be taking on the role to give us an outlook on the future of the 317 immunization program.

What does the expansion of private sector insurance mean for immunization programs?

With financing vaccines being on the top of everyone’s mind in this economic climate, this will be one of the most anticipated sessions of the Congress.

All this and much more will be discussed on April 10th 2012.

Get your questions ready!

Have a look at the Congress program here.

Ensure you join us at the event at the best possible ticket price by booking your place before the 27th January – register here.

Technorati Tags: US government,vaccines,world vaccine congress,vaccine development,vaccine accessibility,policy and advocacy issues,immunization,developing countries,317 immunization program,CDC,private sector insurance

Tags: 317 immunization program, Antibodies, CDC, developing countries, NCIRD, policy and advocacy issues, private sector insurance, US government, vaccine accessibility, vaccine development, Vaccines, world vaccine congress

Upcoming events

full event listing »

Maria Relaki

I am Maria, looking after the Vaccines Congresses in Europe and North America. I'll post some of my own views, but also views of people I am working with in the vaccines industry. If you have anything interesting to share, get in touch!